Free Trial

CytomX Therapeutics (CTMX) SEC Filings & 10K Form

$1.25
-0.01 (-0.40%)
(As of 02:38 PM ET)

Recent CytomX Therapeutics SEC Filings

DateFilerForm TypeView
08/22/2024
4:58 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
4:59 PM
CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:00 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:01 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:01 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
11:15 PM
CytomX Therapeutics (Filer)
Form EFFECT
06/17/2024
3:35 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
4:36 PM
CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:36 PM
CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:31 PM
Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:32 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:33 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:34 PM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:34 PM
CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:00 PM
Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G
05/08/2024
3:41 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
5:06 AM
CytomX Therapeutics (Filer)
Form DEFA14A
04/04/2024
3:31 PM
CytomX Therapeutics (Filer)
Form DEF 14A
04/04/2024
3:33 PM
CytomX Therapeutics (Filer)
Form DEFA14A
03/28/2024
6:12 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:15 PM
CytomX Therapeutics (Filer)
Form PRE 14A
03/22/2024
3:27 PM
CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:36 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:37 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:38 PM
CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:40 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:41 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:30 PM
CytomX Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/19/2024
7:41 PM
CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:43 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:44 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:37 PM
Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:38 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:40 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:54 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:55 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:56 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:57 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:58 PM
CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:12 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:13 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Biden's Executive Order, Dems Digital Money Legislation, First Step To (Ad)

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.
09/22/2023
6:15 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:16 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CTMX) was last updated on 9/13/2024 by MarketBeat.com Staff

From Our Partners